ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 864,70
0,97%
Dow Jones
38 712,21
-0,09%
DAX
18 630,86
1,41%
Brent Oil
82,045
-0,31%
Bitcoin
67 639,15
-0,89%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neon Therapeutics Inc (NTGN)

  7. Neon Therapeutics Inc (NTGN) Actualités

NTGN

Neon Therapeutics (NTGN)

Neon Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTGN
DateHeureSourceTitreSymboleSociété
18/05/202012h09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202023h10Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202023h04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202022h47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTGNNeon Therapeutics Inc
06/05/202016h48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NTGNNeon Therapeutics Inc
01/05/202014h39Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTGNNeon Therapeutics Inc
30/04/202013h00GlobeNewswire Inc.Neon Therapeutics Announces Acceptance of European Clinical Trial Authorization Application for NEO-PTC-01NASDAQ:NTGNNeon Therapeutics Inc
29/04/202023h31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:NTGNNeon Therapeutics Inc
21/04/202022h31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NTGNNeon Therapeutics Inc
11/04/202001h45PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Neon Therapeutics, Inc.NASDAQ:NTGNNeon Therapeutics Inc
02/04/202023h00Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NTGNNeon Therapeutics Inc
02/04/202015h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NTGNNeon Therapeutics Inc
31/03/202012h42GlobeNewswire Inc.BioNTech Announces Full Year 2019 Financial Results and Corporate UpdateNASDAQ:NTGNNeon Therapeutics Inc
25/03/202022h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTGNNeon Therapeutics Inc
23/03/202013h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTGNNeon Therapeutics Inc
02/03/202014h46Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTGNNeon Therapeutics Inc
02/03/202014h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTGNNeon Therapeutics Inc
02/03/202013h00GlobeNewswire Inc.Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business UpdateNASDAQ:NTGNNeon Therapeutics Inc
14/02/202022h11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTGNNeon Therapeutics Inc
27/01/202021h37Edgar (US Regulatory)Schedule 13gNASDAQ:NTGNNeon Therapeutics Inc
23/01/202022h02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NTGNNeon Therapeutics Inc
23/01/202015h57PR Newswire (US)Moore Kuehn, PLLC Encourages NTGN, HXL, FSB, and WMGI Investors to Contact FirmNASDAQ:NTGNNeon Therapeutics Inc
16/01/202013h30GlobeNewswire Inc.BioNTech to acquire Neon to strengthen global leadership position in T cell therapiesNASDAQ:NTGNNeon Therapeutics Inc
18/12/201914h01GlobeNewswire Inc.Neon Therapeutics Submits European Clinical Trial Authorization Application for Personal Neoantigen-Targeted T Cell Therapy N...NASDAQ:NTGNNeon Therapeutics Inc
20/11/201922h05GlobeNewswire Inc.Neon Therapeutics Announces New Strategic Focus on Novel T Cell ProgramsNASDAQ:NTGNNeon Therapeutics Inc
12/11/201913h00GlobeNewswire Inc.Neon Therapeutics Reports Third Quarter 2019 Financial Results and Recent HighlightsNASDAQ:NTGNNeon Therapeutics Inc
08/11/201913h00GlobeNewswire Inc.Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:NTGNNeon Therapeutics Inc
05/09/201922h01GlobeNewswire Inc.Neon Therapeutics Announces Publication in Immunity of Novel Approach to Predict MHC Class II Cancer-Specific NeoantigensNASDAQ:NTGNNeon Therapeutics Inc
06/08/201913h00GlobeNewswire Inc.Neon Therapeutics Reports Second Quarter 2019 Financial ResultsNASDAQ:NTGNNeon Therapeutics Inc
15/07/201915h04Dow Jones NewsNeon Therapeutics Vaccine Study Shows Prolonged Progression-Free SurvivalNASDAQ:NTGNNeon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTGN

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
FTSE
UKX
FTSE 100
EU
ML
Michelin
EU
AI
Air Liquide
EU
CAP
Capgemini
NYSE
MCD
McDonalds
EU
HO
Thales
EU
MC
Lvmh Moet Hennessy Louis...
EU
ORA
Orange
NASDAQ
GOOGL
Alphabet
EU
AF
Air FranceKLM
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés